相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry
N. Puig et al.
LEUKEMIA (2014)
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Prashant R. Tembhare et al.
LEUKEMIA RESEARCH (2014)
Validation of Cell-based Fluorescence Assays: Practice Guidelines from the ICSH and ICCS - Part III - Analytical Issues
Shabnam Tanqri et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Technical issues: flow cytometry and rare event analysis
B. D. Hedley et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2013)
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
Andy C. Rawstron et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL
A. C. Rawstron et al.
LEUKEMIA (2013)
Critical assessment of automated flow cytometry data analysis techniques
Nima Aghaeepour et al.
NATURE METHODS (2013)
Overview of clinical flow cytometry data analysis: recent advances and future challenges
Carlos E. Pedreira et al.
TRENDS IN BIOTECHNOLOGY (2013)
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma
Bruno Paiva et al.
BLOOD (2012)
Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma
Dingsheng Liu et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
J. J. M. van Dongen et al.
LEUKEMIA (2012)
Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
Bruno Paiva et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease
Esther Domingo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping
E. S. Costa et al.
LEUKEMIA (2010)
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients
Bruno Paiva et al.
BLOOD (2009)
Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach
Wendy G. Nieto et al.
BLOOD (2009)
Instability of immunophenotype in plasma cell myeloma
Wenqing Cao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Bruno Paiva et al.
BLOOD (2008)
Generation of flow cytometry data files with a potentially infinite number of dimensions
Carlos E. Pedreira et al.
CYTOMETRY PART A (2008)
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C. Rawstron et al.
HAEMATOLOGICA (2008)
2006 Bethesda international consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia
Brent L. Wood et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2007)
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice
D Subirá et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2002)
分享论文
